New Zealand markets closed

Belite Bio, Inc (BLTE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
42.05-0.45 (-1.06%)
At close: 04:00PM EDT
42.05 -0.46 (-1.08%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
6,236
24,844
8,869
7,419
3,688
Selling general and administrative
2,322
6,824
3,952
2,378
2,055
Total operating expenses
8,558
31,668
12,821
9,797
5,743
Operating income or loss
-8,558
-31,668
-12,821
-9,797
-5,743
Interest expense
25
25
16
0
21
Total other income/expenses net
147
-4
166
126
-
Income before tax
-8,406
-31,623
-12,648
-9,666
-5,752
Income tax expense
0
9
0
0
1
Income from continuing operations
-8,406
-31,632
-12,648
-9,666
-5,753
Net income
-8,406
-31,632
-12,648
-9,666
-5,753
Net income available to common shareholders
-8,406
-31,632
-12,648
-9,666
-5,753
Basic EPS
-1.26
-1.19
-0.63
-0.40
-0.24
Diluted EPS
-1.26
-1.19
-0.63
-0.40
-0.24
Basic average shares
25,746
26,594
19,977
24,095
24,095
Diluted average shares
25,746
26,594
19,977
24,095
24,095